Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Peter, de Blank"'
Autor:
Sukanya Iyer, Marwa Ismail, Benita Tamrazi, Ralph Salloum, Peter de Blank, Ashley Margol, Ramon Correa, Jonathan Chen, Kaustav Bera, Volodymyr Statsevych, Mai-Lan Ho, Pranjal Vaidya, Ruchika Verma, Debra Hawes, Alexander Judkins, Pingfu Fu, Anant Madabhushi, Pallavi Tiwari
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionMedulloblastoma (MB) is a malignant, heterogenous brain tumor. Advances in molecular profiling have led to identifying four molecular subgroups of MB (WNT, SHH, Group 3, Group 4), each with distinct clinical behaviors. We hypothesize that
Externí odkaz:
https://doaj.org/article/fa3bbee293b045198feb0c616919a64e
Publikováno v:
Diagnostics, Vol 13, Iss 17, p 2727 (2023)
Recent advances in artificial intelligence have greatly impacted the field of medical imaging and vastly improved the development of computational algorithms for data analysis. In the field of pediatric neuro-oncology, radiomics, the process of obtai
Externí odkaz:
https://doaj.org/article/4c9d62272a3f4ab381e8b5279003c4f3
Autor:
Margot A. Lazow, Lindsey Hoffman, Austin Schafer, Diana S. Osorio, Daniel R. Boué, Sarah Rush, Erin Wright, Adam Lane, Mariko D. DeWire-Schottmiller, Teresa Smolarek, Jared Sipple, Heather Taggert, Jaime Reuss, Ralph Salloum, Trent R. Hummel, Peter de Blank, Natasha Pillay-Smiley, Mary E. Sutton, Anthony Asher, Charles B. Stevenson, Rachid Drissi, Jonathan L. Finlay, Maryam Fouladi, Christine Fuller
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-20 (2020)
Abstract Recent discoveries have provided valuable insight into the genomic landscape of pediatric low-grade gliomas (LGGs) at diagnosis, facilitating molecularly targeted treatment. However, little is known about their temporal and therapy-related g
Externí odkaz:
https://doaj.org/article/607bcb863f014400af67f505d77ca7c7
Autor:
Ina Ly, Tianyu Liu, Wenli Cai, Olivia Michaels, Maya Viera, Daniel Kwon, Miriam Bredella, Justin Jordan, Dana Borcherding, Demetrius Boswell, Crystal Burgess, Ping Chi, Peter de Blank, Eva Dombi, Angela Hirbe, Bruce Korf, Shernine Lee, Victor Mautner, Mairim Melecio-Vazquez, Zachary Mulder, Kai Pollard, Christine Pratilas, Johannes Salamon, Divya Srihari, Matthew Steensma, Brigitte Widemann, Jaishri Blakeley, Scott Plotkin
Publikováno v:
Monday, April 24.
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2109
Background: Understanding the effect of selumetinib on FASI may help elucidate the biology, proliferative potential, and role in neurocognitive changes for these NF1-associated lesions. Methods: Patients with NF1-associated LGG and FASI treated with
Autor:
Margot A Lazow, Martijn T Nievelstein, Adam Lane, Pratiti Bandopadhayhay, Mariko DeWire-Schottmiller, Maryam Fouladi, John W Glod, Robert J Greiner, Lindsey M Hoffman, Trent R Hummel, Lindsay Kilburn, Sarah Leary, Jane E Minturn, Roger Packer, David S Ziegler, Brooklyn Chaney, Katie Black, Peter de Blank, James L Leach
Publikováno v:
Neuro Oncol
Background Cross-sectional tumor measures are traditional clinical trial endpoints; however volumetric measures may better assess tumor growth. We determined the correlation and compared the prognostic impact of cross-sectional and volumetric measure
Autor:
Chelsea Kotch, Robert Avery, Kelly D Getz, Eric Bouffet, Peter de Blank, Robert Listernick, David H Gutmann, Miriam Bornhorst, Cynthia Campen, Grant T Liu, Richard Aplenc, Yimei Li, Michael J Fisher
Publikováno v:
Neuro Oncol
Background Nearly one-third of patients with neurofibromatosis type 1-associated optic pathway glioma (NF1-OPG) fail frontline chemotherapy; however, little is known about risk factors for treatment failure. Methods We performed a retrospective multi
Autor:
Mary Anne Toledo-Tamula, Pamela L. Wolters, Kristina K. Hardy, Jonathan M. Payne, Karin S. Walsh, Tena Rosser, Heather L. Thompson, Peter de Blank, Allison del Castillo, Bonita P. Klein-Tasman, Staci Martin, Maureen Hussey, Nicole J. Ullrich, Kristina M Haebich, Jennifer Janusz
Publikováno v:
Neurology
ObjectiveTo review parent-report social skills measures to identify and recommend consensus outcomes for use in clinical trials of social deficit in children and adolescents (ages 6–18 years) with neurofibromatosis type 1 (NF1).MethodsSearches were
Autor:
Elizabeth Gilger, Mariko DeWire, Wanda Meriwether, Shiva Senthil Kumar, Dinah Meister, Maureen Gallagher, Trent R. Hummel, Lori Driver, Anthony Asher, Christine Fuller, Natasha Pillay-Smiley, Lindsey Hoffman, Rachid Drissi, Susan Jelinek, Ralph Salloum, Blaise V. Jones, James L. Leach, Lionel M L Chow, Peter de Blank, Satarupa Sengupta, Maryam Fouladi, Heather Ward, Bridget Kikta, Lili Miles, Craig Erker
Publikováno v:
Journal of Neuro-Oncology. 152:107-114
While autopsy-repository programs with a variety of pediatric central nervous system (CNS) tumor types are a critical resource for preclinical neuro-oncology research, few exist and there is no published guidance on how to develop one. The goal of th
Autor:
Ina Ly, Tianyu Liu, Wenli Cai, Olivia Michaels, Daniel Kwon, Miriam Bredella, Justin Jordan, Dana Borcherding, Demetrius Boswell, Crystal Burgess, Ping Chi, Peter de Blank, Eva Dombi, Angela Hirbe, Bruce Korf, Shernine Lee, Victor Mautner, Mairim Melecio-Vázquez, Zachary Mulder, Kai Pollard, Christine Pratilas, Johannes Salamon, Divya Srihari, Matthew Steensma, Brigitte Widemann, Jaishri Blakeley, Scott Plotkin
Publikováno v:
Neuro-Oncology. 24:vii164-vii165
BACKGROUND Plexiform neurofibromas (PNF) and malignant peripheral nerve sheath tumors (MPNST) are best visualized on short TI inversion recovery (STIR) sequences on MRI. However, STIR sequences are not routinely acquired in the clinical setting. T1-w